Contact Us
Drug Search Results
More Filters [+]

Indeglitazar

Alternative Names: indeglitazar, ppm-204, ppm204, ppm 204
Latest Update: 2023-12-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PPAR-a Agonist,PPAR-d Agonist,PPAR-g Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Pfizer
Company Location: NEW YORK NY 10017
Company CEO: Albert Bourla
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Indeglitazar

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Type 2 Diabetes

Phase 1: General Diabetes|Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2006-003897-87

P2

Completed

Type 2 Diabetes

2009-01-19

2005-004227-19

P2

Completed

Type 2 Diabetes

2007-02-08

3180A1-1109

P1

Completed

General Diabetes|Healthy Volunteers

None

3180A1-107

P1

Completed

General Diabetes|Healthy Volunteers

None

Recent News Events

Date

Type

Title

12/15/2023

PubMed

 Design, synthesis, and biological evaluation of deuterated indolepropionic acid derivatives as novel long-acting pan PPARα/γ/δ agonists.

02/06/2023

PubMed

 Quercetin ameliorates hepatic fat accumulation in high-fat diet-induced obese mice via PPARs.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions